semaglutide shortage resolved As of February 21, 2025, the FDA updated its drug list, marking the injection shortage as resolved. Semaglutide injections are no longer classified as “currently in shortage,” and both 503A Semaglutide Shortage Ends: Compounded Versions
Description
JourneyLite offers medically supervised oral weight loss programs with personalized dosing and ongoing support.

PlexusDx provides personalized guidance based on your health profile
Very well written and comprehensive comparison Very informative table for RWE studies comparing tirzepoatide vs semaglutide The only addition/correction I would make is that both tirzepatide and semaglutide have trials in patients with HFpEF and both with very positive results #tirzepatide #semaglutide #obesity #type2diabetes #cardiovascularcomplications #rwe

GLP-1 drugs have had a pretty wild rise

PlexusDx offers compounded oral semaglutide starting at $249/mo, with personalized dosing based on your health profile and genetic insights

Tirzepatide Cuts Risk of Diabetes by 94% in Prediabetic Adults
